Getting genetic access to natural adenovirus genomes to explore vector diversity
- PMID: 28711987
- DOI: 10.1007/s11262-017-1487-2
Getting genetic access to natural adenovirus genomes to explore vector diversity
Abstract
Recombinant vectors based on the human adenovirus type 5 (HAdV5) have been developed and extensively used in preclinical and clinical studies for over 30 years. However, certain restrictions of HAdV5-based vectors have limited their clinical applications because they are rather inefficient in specifically transducing cells of therapeutic interest that lack the coxsackievirus and adenovirus receptor (CAR). Moreover, enhanced vector-associated toxicity and widespread preexisting immunity have been shown to significantly hamper the effectiveness of HAdV-5-mediated gene transfer. However, evolution of adenoviruses in the natural host is driving the generation of novel types with altered virulence, enhanced transmission, and altered tissue tropism. As a consequence, an increasing number of alternative adenovirus types were identified, which may represent a valuable resource for the development of novel vector types. Thus, researchers are focusing on the other naturally occurring adenovirus types, which are structurally similar but functionally different from HAdV5. To this end, several strategies have been devised for getting genetic access to adenovirus genomes, resulting in a new panel of adenoviral vectors. Importantly, these vectors were shown to have a host range different from HAdV5 and to escape the anti-HAdV5 immune response, thus underlining the great potential of this approach. In summary, this review provides a state-of-the-art overview of one essential step in adenoviral vector development.
Keywords: Adenovirus; Adenovirus diversity, cloning; Gene medicine; Vectorization.
Similar articles
-
Development of an AdEasy-based system to produce first- and second-generation adenoviral vectors with tropism for CAR- or CD46-positive cells.J Gene Med. 2013 Jan;15(1):1-11. doi: 10.1002/jgm.2687. J Gene Med. 2013. PMID: 23225636
-
Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5-based Constructs.Mol Ther. 2016 Feb;24(1):6-16. doi: 10.1038/mt.2015.194. Epub 2015 Oct 19. Mol Ther. 2016. PMID: 26478249 Free PMC article. Review.
-
Adenovirus vectors based on human adenovirus type 19a have high potential for human muscle-directed gene therapy.Hum Gene Ther. 2006 Feb;17(2):193-205. doi: 10.1089/hum.2006.17.193. Hum Gene Ther. 2006. PMID: 16454653
-
Human AdV-20-42-42, a Promising Novel Adenoviral Vector for Gene Therapy and Vaccine Product Development.J Virol. 2021 Oct 27;95(22):e0038721. doi: 10.1128/JVI.00387-21. Epub 2021 Sep 1. J Virol. 2021. PMID: 34469243 Free PMC article.
-
State-of-the-art human adenovirus vectorology for therapeutic approaches.FEBS Lett. 2019 Dec;593(24):3609-3622. doi: 10.1002/1873-3468.13691. Epub 2019 Dec 9. FEBS Lett. 2019. PMID: 31758807 Review.
Cited by
-
High-Throughput Cloning and Characterization of Emerging Adenovirus Types 70, 73, 74, and 75.Int J Mol Sci. 2020 Sep 2;21(17):6370. doi: 10.3390/ijms21176370. Int J Mol Sci. 2020. PMID: 32887347 Free PMC article.
-
Construction and Characterization of Adenovirus Vectors Encoding Aspartate-β-Hydroxylase to Preliminary Application in Immunotherapy of Hepatocellular Carcinoma.J Immunol Res. 2018 Jul 15;2018:9832467. doi: 10.1155/2018/9832467. eCollection 2018. J Immunol Res. 2018. PMID: 30116759 Free PMC article.
-
The Adenovirus Vector Platform: Novel Insights into Rational Vector Design and Lessons Learned from the COVID-19 Vaccine.Viruses. 2023 Jan 11;15(1):204. doi: 10.3390/v15010204. Viruses. 2023. PMID: 36680244 Free PMC article. Review.
-
Adenoviral Vectors Armed with PAPILLOMAVIRUs Oncogene Specific CRISPR/Cas9 Kill Human-Papillomavirus-Induced Cervical Cancer Cells.Cancers (Basel). 2020 Jul 17;12(7):1934. doi: 10.3390/cancers12071934. Cancers (Basel). 2020. PMID: 32708897 Free PMC article.
-
Effect of cold atmospheric plasma (CAP) on human adenoviruses is adenovirus type-dependent.PLoS One. 2018 Oct 26;13(10):e0202352. doi: 10.1371/journal.pone.0202352. eCollection 2018. PLoS One. 2018. PMID: 30365500 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials